Decyclohexanamine-Exatecan

• UNSPSC Description:

  Decyclohexanamine-Exatecan is a Camptothecin derivative, compound a, extracted from patent WO2020219287 A1.

• Target Antigen:

  ADC Cytotoxin; Topoisomerase

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/decyclohexanamine-exatecan.html

• Solubility:

  DMSO : ≥ 32 mg/mL

• Smiles:

  CC[C@@]1(C2=C(COC1=O)C(N3C(C(C(C3)=CC4=C5)=NC4=CC(F)=C5C)=C2)=O)O

• Molecular Weight:

  380.37

• References & Citations:

  [1]Ravi Chari, et al. Camptothecin derivatives. Patent WO2020219287 A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2505045-51-0